The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
Dubravka Bobek(University Hospital Centre Zagreb), Marija Jelušić(Unknown), Ivan Krešimir Lukić(University of Split), Danka Grčević(University of Zagreb), Nataša Kovačić(University of Zagreb)
Cited by 46
Related Papers
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers
|PLoS Genetics|2013|376
Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus
|Nature Communications|2019|122
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis
|Annals of the Rheumatic Diseases|2019|109
Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?
|Pediatric Rheumatology|2019|94